Getting the most mileage from donated heartsTERASAKI, P.The Annals of thoracic surgery. 1990, Vol 49, Num 2, pp 177-178, issn 0003-4975, 2 p.Article

Nationwide organ sharing using HLA typingTERASAKI, P. I.Kidney international. 1991, Vol 39, Num 3, pp 557-567, issn 0085-2538Article

Histocompatibility testing in transplantationTERASAKI, P. I.Archives of pathology & laboratory medicine (1976). 1991, Vol 115, Num 3, pp 250-254, issn 0363-0153Conference Paper

The beneficial transfusion effect on kidney graft survival attributed to clonal deletionTERASAKI, P. I.Transplantation. 1984, Vol 37, Num 2, pp 119-125, issn 0041-1337Article

OKT3 treatment of steroid-resistant rejection in pediatric liver transplant recipientsMCDIARMID, S. V; BUSUTTIL, R. W; TERASAKI, P et al.Journal of pediatric gastroenterology and nutrition. 1992, Vol 14, Num 1, pp 86-91, issn 0277-2116Article

HLA-DR matching in multicenter, single-typing laboratory dataAYOUB, G; TERASAKI, P.Transplantation. 1982, Vol 33, Num 5, pp 515-517, issn 0041-1337Article

The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patientsMIZUTANI, K; TERASAKI, P; HAMDANI, E et al.American journal of transplantation (Print). 2007, Vol 7, Num 4, pp 1027-1031, issn 1600-6135, 5 p.Article

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantationSTARZL, T. E; DEMETRIS, A. J; MURASE, N et al.Transplantation. 1993, Vol 55, Num 6, pp 1272-1277, issn 0041-1337Article

Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipientsKAHAN, B. D; MICKEY, R; FLECHNER, S. M et al.Transplantation. 1987, Vol 43, Num 1, pp 65-70, issn 0041-1337Conference Paper

Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patientsMCDIARMID, S. V; MILLIS, M; TERASHITA, G et al.Transplantation proceedings. 1990, Vol 22, Num 4, pp 1774-1776, issn 0041-1345, 3 p.Conference Paper

Characterization of monoclonal antibodies CBL3 and TT62 with differing antigenic determinants specific for isolated human isletsSOON-SHIONG, P; HEINTZ, R; TERASAKI, P et al.Biochemical and biophysical research communications (Print). 1988, Vol 150, Num 2, pp 775-780, issn 0006-291X, 6 p.Article

Detection of tumor-associated antigens in the sera of lung cancer patients by three monoclonal antibodiesHIROTA, M; FUKUSHIMA, K; TERASAKI, P et al.Cancer research (Baltimore). 1985, Vol 45, Num 12, pp 6453-6456, issn 0008-5472Article

A comparison of kidney transplant survival in white and black recipientsTAKEMOTO, S; TERASAKI, P. I.Transplantation proceedings. 1989, Vol 21, Num 6, pp 3865-3868, issn 0041-1345Conference Paper

A MONOCLONAL ANTIBODY RECOGNIZING A DETERMINANT COMMON TO HLA-A3 AND A11 = UN ANTICORPS MONOCLONAL RECONNAISSANT UN DETERMINANT COMMUN A HLA-A3 ET A11BILLING R; CLARK B; LUCERO K et al.1982; TISSUE ANTIGENS; ISSN 0001-2815; DNK; DA. 1982; VOL. 19; NO 2; PP. 121-128; BIBL. 15 REF.Article

MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN T ACUTE LYMPHOBLASTIC LEUKAEMIACHUN TSAN DENG; TERASAKI P; CHIA J et al.1982; LANCET (BR. ED.); ISSN 0140-6736; GBR; DA. 1982; NO 8262; PP. 10-11; BIBL. 9 REF.Article

RED BLOOD CELL COLD AGGLUTININS AND B LYMPHOCYTE CYTOTOXINS IN BREAST CANCER SERADUBE V; TWAKI Y; ANDERSON B et al.1982; VOX SANG.; ISSN 0042-9007; CHE; DA. 1982; VOL. 43; NO 3; PP. 113-121; BIBL. 22 REF.Article

HLA TYPING IN RETINITIS PIGMENTOSAHECKENLIVELY JR; BASTEK JV; PEARLMAN JT et al.1981; BR. J. OPHTHALMOL.; ISSN 0007-1161; GBR; DA. 1981 PUBL. 1980; VOL. 65; NO 2; PP. 131-132; BIBL. 8 REF.Article

Influence of HLA and CREG matching in African-American primary cadaver kidney recipients : UNOS 1991-1995SCANTLEBURY, V; GJERTSON, D; ELIASZIW, M et al.Transplantation proceedings. 1997, Vol 29, Num 8, pp 3733-3736, issn 0041-1345Conference Paper

Pretransplant panel reactive-antibody screens : Are they truly a marker for poor outcome after cardiac transplantation ?KOBASHIGAWA, J. A; SABAD, A; DRINKWATER, D et al.Circulation (New York, N.Y.). 1996, Vol 94, Num 9, pp 294-297, issn 0009-7322, SUPConference Paper

Matching cadaver transplants achieve graft survivals comparable to living related transplantsCICCIARELLI, J; TERASAKI, P.Transplantation proceedings. 1991, Vol 23, Num 1, pp 1284-1288, issn 0041-1345, 2Conference Paper

Islet purification by a novel immunomicrosphere cell depletion techniqueSOON-SHIONG, P; FUJIOKA, T; TERASAKI, P et al.Transplantation proceedings. 1990, Vol 22, Num 2, pp 780-781, issn 0041-1345, 2 p.Conference Paper

Clinical application of four tumor markers in monitoring of cancer patientsCHIA, D; TERASAKI, P; ROSENBLOOM, B et al.Journal of tumor marker oncology. 1989, Vol 4, Num 4, pp 349-353, issn 0886-3849Article

Kidney transplant in black recipients : HLA matching and other factors affecting long-term graft survivalKOYAMA, H; CECKA, J. M; TERASAKI, P. I et al.Transplantation. 1994, Vol 57, Num 7, pp 1064-1068, issn 0041-1337Article

Repeating HLA antigen mismatches in renal retransplants : a second class mistake ?CECKA, J. M; TERASAKI, P. I.Transplantation. 1994, Vol 57, Num 4, pp 515-519, issn 0041-1337Conference Paper

INDUCIBILITY OF THE EPSTEIN-BARR VIRUS (EBV) CYCLE AND SURFACE MARKER PROPERTIES OF EBV-NEGATIVE LYMPHOMA LINES AND THEIR IN VITRO EBV-CONVERTED SUBLINES.KLEIN G; ZEUTHEN J; TERASAKI P et al.1976; INTERNATION. J. CANCER; SWITZ.; DA. 1976; VOL. 18; NO 5; PP. 639-652; ABS. FR.; BIBL. 1 P.Article